Finance Integration And Expansion Lead, Planned Expansions In The Us And Italy (Catalent Deal)
CurrentResponsibilities within all financial matters as Finance Expansion lead supporting establishment of two project organizations that can execute upon approval. Hence establishment in US and Italy of ERP system set-up (Finance-, HR-, Procurement, CAPEX-modules etc.), Legal company creation, Treasury-, cash pool- and internal banking set-up. This in close cooperation with global process owners, functional stakeholders and NN process and governance/compliance. Novo Nordisk initiated in Q2 2024 planning of a capacity expansion that can be executed on once the acquisition of Catalent is approved by competition authorities (see below link).Link: https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=167017